Table 1.
Baseline characteristics
| Patients, No. (%) | |||
|---|---|---|---|
| All (n = 286) | Low NLR (n = 158) | High NLR (n = 128) | |
| Age | |||
| < 65 | 48 (16.8) | 27 (17.1) | 21 (16.4) |
| ≥ 65 | 238 (83.2) | 131 (82.9) | 107 (83.6) |
| Gender | |||
| Male | 122 (42.7) | 61 (38.6) | 61 (47.7) |
| Female | 164 (57.3) | 97 (61.4) | 67 (52.3) |
| Race | |||
| White | 271 (94.8) | 148 (93.7) | 123 (96.1) |
| Other | 15 (5.2) | 10 (6.3) | 5 (3.9) |
| KPS | |||
| 70–100 | 178 (62.2) | 101 (63.9) | 77 (60.2) |
| < 70 | 108 (37.8) | 57 (36.1) | 51 (39.8) |
| Histology | |||
| Adenocarcinoma | 160 (55.9) | 92 (58.2) | 68 (53.1) |
| Squamous Cell | 93 (32.5) | 47 (29.7) | 46 (35.9) |
| NSCLC (NOS) | 33 (11.5) | 19 (12.0) | 14 (10.9) |
| Site | |||
| Left | 140 (49.0) | 80 (50.6) | 60 (46.9) |
| Right | 146 (51.0) | 78 (49.4) | 68 (53.1) |
| T staging | |||
| 1 | 235 (82.2) | 136 (86.1) | 99 (77.3) |
| 2 | 51 (17.8) | 22 (13.9) | 29 (22.7) |
| Fractions | |||
| 1 | 211 (72.8) | 117 (74.1) | 94 (73.4) |
| 3 | 75 (26.2) | 41 (25.9) | 34 (26.6) |
| Smoking Status | |||
| Current | 79 (27.6) | 50 (31.6) | 29 (22.7) |
| Former | 188 (65.7) | 97 (61.4) | 91 (71.1) |
| Never | 19 (6.6) | 11 (7.0) | 8 (6.3) |
| Year of radiation | |||
| 2013 or earlier | 220 (76.9) | 125 (79.1) | 95 (74.2) |
| 2013 or later | 66 (23.1) | 33 (20.9) | 33 (25.8) |
N number, KPS Karnofsky performance, NOS not otherwise specified